US firm snaps up Dublin diagnostics gem Biosensia
Company: Biosensia
Done Deal: US acquisition
The clincher:“We are very excited about bringing our advanced platform together with Kypha’s specialised biomarker testing and achieving the clinical impact that we designed RapiPlex to fulfil” - Niamh O’Luanaigh, chief operating officer, Biosensia
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Tom Maguire: Tax changes we make now could help business for years
The way we did business a few months ago may never return – so the opportunity is to make changes that will both aid recovery and set us up well for our new futures
The Daily Briefing
What’s coming up today and what you might have missed
The Daily Briefing
What’s coming up today and what you might have missed.
